Literature DB >> 19746193

A Semiparametric Bayesian Model for Repeatedly Repeated Binary Outcomes.

Fernando A Quintana1, Peter Müller, Gary L Rosner, Mary V Relling.   

Abstract

We discuss the analysis of data from single nucleotide polymorphism (SNP) arrays comparing tumor and normal tissues. The data consist of sequences of indicators for loss of heterozygosity (LOH) and involve three nested levels of repetition: chromosomes for a given patient, regions within chromosomes, and SNPs nested within regions. We propose to analyze these data using a semiparametric model for multi-level repeated binary data. At the top level of the hierarchy we assume a sampling model for the observed binary LOH sequences that arises from a partial exchangeability argument. This implies a mixture of Markov chains model. The mixture is defined with respect to the Markov transition probabilities. We assume a nonparametric prior for the random mixing measure. The resulting model takes the form of a semiparametric random effects model with the matrix of transition probabilities being the random effects. The model includes appropriate dependence assumptions for the two remaining levels of the hierarchy, i.e., for regions within chromosomes and for chromosomes within patient. We use the model to identify regions of increased LOH in a dataset coming from a study of treatment-related leukemia in children with an initial cancer diagnostic. The model successfully identifies the desired regions and performs well compared to other available alternatives.

Entities:  

Year:  2008        PMID: 19746193      PMCID: PMC2739390          DOI: 10.1111/j.1467-9876.2008.00619.x

Source DB:  PubMed          Journal:  J R Stat Soc Ser C Appl Stat        ISSN: 0035-9254            Impact factor:   1.864


  9 in total

1.  dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data.

Authors:  Ming Lin; Lee-Jen Wei; William R Sellers; Marshall Lieberfarb; Wing Hung Wong; Cheng Li
Journal:  Bioinformatics       Date:  2004-02-10       Impact factor: 6.937

2.  Insights into leukemogenesis from therapy-related leukemia.

Authors:  Jens Pedersen-Bjergaard
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

3.  Semiparametric bayesian inference for multilevel repeated measurement data.

Authors:  Peter Müller; Fernando A Quintana; Gary L Rosner
Journal:  Biometrics       Date:  2007-03       Impact factor: 2.571

4.  A semiparametric Bayesian approach to the random effects model.

Authors:  K P Kleinman; J G Ibrahim
Journal:  Biometrics       Date:  1998-09       Impact factor: 2.571

5.  Inferring the location and effect of tumor suppressor genes by instability-selection modeling of allelic-loss data.

Authors:  M A Newton; Y Lee
Journal:  Biometrics       Date:  2000-12       Impact factor: 2.571

6.  Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment.

Authors:  Mary V Relling; James M Boyett; Javier G Blanco; Susana Raimondi; Frederick G Behm; John T Sandlund; Gaston K Rivera; Larry E Kun; William E Evans; Ching-Hon Pui
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

7.  On the statistical analysis of allelic-loss data.

Authors:  M A Newton; M N Gould; C A Reznikoff; J D Haag
Journal:  Stat Med       Date:  1998-07-15       Impact factor: 2.373

8.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

9.  Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.

Authors:  Rameen Beroukhim; Ming Lin; Yuhyun Park; Ke Hao; Xiaojun Zhao; Levi A Garraway; Edward A Fox; Ephraim P Hochberg; Ingo K Mellinghoff; Matthias D Hofer; Aurelien Descazeaud; Mark A Rubin; Matthew Meyerson; Wing Hung Wong; William R Sellers; Cheng Li
Journal:  PLoS Comput Biol       Date:  2006-05-12       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.